THE ARISING · DAILY EDITION
The Arising — October 24, 2026
Download the PDF ↓Longevity & Healthspan
Faster Epigenetic Aging Linked to Higher Death Risk Across 381,000 Adults, Meta-Analysis Finds
Among the many tests that claim to measure biological age, one family of blood-based tests now has a large body of evidence behind it: people whose DNA looks older than their calendar age tend to die sooner, as a group, than people whose DNA looks younger.
Reading medical evidence →Sleep Shortened and Shifted Later as Electricity Reached Argentine Communities, Study Finds
Over 12 years, researchers watched sleep change in Indigenous Toba/Qom communities in northern Argentina as electricity, then the internet and smartphones, arrived. Sleep moved later in every group studied, and in rural communities it also grew shorter by about an hour.
Sleep →Exercise for Mild Cognitive Impairment: Network Meta-Analysis Ranking Could Not Be Confirmed
When memory starts to slip, which kind of exercise is the best bet? An iScience network meta-analysis addresses that question. We could not confirm its findings. Our research notes say it ranked combined physical and brain training as most likely best, but nothing we retrieved verifies that, so treat it as unconfirmed.
Brain health →FDA Clears AI Tool Estimating Alzheimer's Risk in Mild Cognitive Impairment
For people with mild memory problems, the hardest question is often what comes next, and a newly cleared software tool is designed to help doctors address it.
Brain health →Low Activity Plus Weak Grip Linked to Higher Cognitive Impairment Risk
Adults who stayed both physically inactive and physically weak over several years were more likely to develop cognitive impairment later, according to a large study of older adults in the United States, China and South Korea.
Strength and function →Review of 248 Studies Ranks Protein Plus Strength Training Top for Sarcopenia
Of all the diet strategies tested against age-related muscle loss, a protein intake of at least 1.0 to 1.2 grams per kilogram of body weight a day, paired with resistance training, has the strongest support, according to a new review of 248 studies.
Strength and function →Amylin Drug Petrelintide Cut Weight Up to 9.2% in Diabetes Trial
Side effects are often what decide whether someone can stay on a weight-loss drug. In a new mid-stage trial, almost no one taking an experimental weekly injection called petrelintide quit because of stomach problems, according to Longevity.Technology's report of the study.
Reading medical evidence →Hearing and Vision Loss Linked to Body-Mind-Memory Decline, Partly via Loneliness
Adults aged 45 and older who had both sight and hearing loss were more likely to go on to develop physical disease, a psychological disorder and cognitive impairment together, and loneliness appears to explain a small part of why.
Brain health →NAD+ and Calorie Restriction May Work Through Brain Cell Antennae in Mice
Eating less is one of the best-studied ways to slow aging in animals, and a new study suggests that part of its effect may run through tiny antenna-like structures on brain cells.
Brain health →Heart Amyloid Drug Tafamidis Linked to Healthier Blood Vessel Cells
Blood from people with a heart-weakening protein disease harmed human blood vessel cells in the lab, and blood taken after six months of treatment with the drug tafamidis harmed them less. That is the central finding of a new study in Amyloid, and it hints that the condition may reach beyond the heart.
Strength and function →Eye Gene Therapy Linked to Vision Gains in Stargardt, Heads to Geographic Atrophy Trial
For older adults with advanced dry macular degeneration, today's approved treatments can slow the damage but cannot bring back sight that is already lost. A one-time eye injection now headed for a new trial aims at that gap, though the evidence for this disease is still limited to animals.
Reading medical evidence →Stair-Climb Test Gave Only Rough Estimate of Aerobic Fitness
Climbing a few flights of stairs at a brisk pace is easy to do anywhere. A small new study asked how much that simple act can reveal about aerobic fitness, a key marker of healthy aging. The answer, according to the researchers: something, but not much precision.
Strength and function →Body-Clock 'Circadian Depression' Subtype Found in a Quarter of Patients
People with depression who are night owls, sleep long hours and wake up exhausted may belong to a distinct group that responds less well to common antidepressants, according to a new Australian study.
Sleep →Epigenetic Age Acceleration Tracks Kidney Disease Progression in Type 1 Diabetes
People with type 1 diabetes and kidney disease looked about two years older on a DNA-based age measure than people with type 1 diabetes whose kidneys were spared, according to a new study in the journal Diabetes.
Brain health →Most Epigenetic Aging Clocks Fail to Predict Dementia, Meta-Analysis Finds
Epigenetic age tests promise to measure how fast a body is aging. A new pooled analysis suggests that, for dementia, most of them say little.
Brain health →Review in Public Health Asks Whether Exercise Timing Affects Heart and Metabolic Markers
Morning or evening? A new review in Public Health takes on one of the most common questions about exercise: does the time of day change what a workout does for heart and metabolic health?
Strength and function →Fasting Mimicking Diet Programme for Diabetes and Obesity Reaches UK Clinics
People in the UK with type 2 diabetes or obesity may soon be able to try a medically supervised fasting-based programme through their clinic, and the first practice began enrolling patients this week.
Reading medical evidence →AI Drug Firm Pathos Raises $237 Million, Shifts Toward Alzheimer's
A company that uses artificial intelligence to decide which drugs to develop is turning its attention to Alzheimer's disease, and a major drugmaker is putting money behind the move.
Brain health →APA Survey: Most Americans Accept Chronic Stress, Nearly Half Withdraw Socially
Most American adults now treat stress as a fact of life, and nearly half say it has led them to pull back from other people, according to the American Psychological Association's 2026 Stress in America survey.
Reading medical evidence →Tiny Peptide Alleviates Artery Calcification in Mice by Changing Cell Energy Use
Arteries can slowly fill with mineral deposits that make them stiff, and a new study in mice points to a cell-level energy switch that may drive the process.
Strength and function →Hormone Therapy Linked to More Frequent, Longer Migraines After Menopause
Women who use hormone therapy after menopause may have migraines that come more often and last longer, according to The Menopause Society's report of a new analysis. But the same report says the findings may not mean the therapy is the cause.
Brain health →Meta-Analysis Examines Which Exercise, and How Much, Relates to Sleep in Older Adults
A new systematic review asks a practical question for people past midlife who sleep badly: which kind of exercise helps, and how much?
Strength and function →2,711 Autopsies Show Alzheimer's Brain Changes Are Rare Before 70
Among 2,711 people whose brains were examined after death in São Paulo, Alzheimer's-type changes at levels a current biomarker test can detect were uncommon before age 70, and brain disease that those tests do not detect was linked to cognitive impairment about as often as advanced Alzheimer's changes were.
Brain health →Does Pregnancy's Biological Aging Fully Reverse? A Hypothesis Awaits Testing
Childbirth leaves a measurable mark on the body, and for many measures it takes months to fade. A large analysis of routine lab tests found that about half of 76 tests needed between three months and a year after delivery to return to baseline. Whether recovery time shapes long-term aging is a hypothesis proposed by a recent review, not an established finding.
Brain health →Diet, Exercise and Empagliflozin Matched on Blood Sugar in Older Diabetics
In a small randomised trial of adults aged 65 and older with type 2 diabetes, a Mediterranean-style diet, resistance exercise and the drug empagliflozin all improved blood sugar control, and the differences between them were not statistically significant.
Strength and function →Review Finds Ultra-Processed Food Subtypes Differ Sharply in Diabetes Risk
Ultra-processed food is often discussed as one thing, but a new review in BMC Medicine finds that its subtypes may not move type 2 diabetes risk in the same direction.
Brain health →AI-Designed Peptide Targeting Zombie Cells Heads Toward First Human Testing
A molecule just nine amino acids long may be the next test of whether the immune system can be taught to clear out aging cells, but so far the evidence comes from the company that made it.
Brain health →Blocking Lactate Exporter MCT4 Improved Aged Egg Quality in Lab Study
Eggs age, and so far scientists have understood that process mainly through the RNA messages inside them. A new study in Nature Communications looked at the proteins instead, and found a possible metabolic lever: a protein called MCT4, which moves lactate out of the cell.
Brain health →Aquatic and Dance Exercise Accompanied Lower Inflammation in Obese Older Women
Twelve weeks of aquatic or dance-based aerobic exercise went along with less body fat, lower levels of an inflammation marker and better scores on a thinking test in older women with obesity, according to a new randomized trial.
Strength and function →Aging Brain Cells Keep Their Identity, Challenging Epigenetic Drift Theory
A common idea in aging science says that as we get older, our cells slowly lose track of what they are. A new mouse study suggests that, in the brain at least, this is not what happens.
Brain health →
Markets & Strategy
Longevity Funding Nearly Quadruples as Investors Concentrate on Fewer, Later-Stage Companies
Money flowing into longevity biotech has grown sharply, but it is going to fewer companies at later stages. According to Longevity.Technology's Longevity Biotech Report, investment rose from $4.7 billion in 2024 to $18.4 billion in 2025, and $12.1 billion is already in for 2026.
Longevity in daily life →Fractyl Cuts 45% of Staff to Focus on Revita After Pivotal Win
Fractyl is cutting about 45% of its workforce and putting what is left of its money behind one product: Revita, a procedure it hopes will help people keep weight off after they stop GLP-1 drugs. Revita is not FDAauthorized in the U.S.; it holds Breakthrough Device designation only, so it is not currently available to U.S. patients outside trials.
GLP-1 medicines →CMS and States Launch $275M Program to Recruit Nursing Home Nurses
The federal government and the states have put $275 million behind a plan to bring nurses into nursing homes, and the money comes from fines the industry has already paid.
Care and connection →Insurers Split on How the Pandemic Should Shape Future Mortality Assumptions
Insurers that price life policies and annuities still do not agree on what the pandemic means for how long people will live. That is the central finding of a new industry survey, and it matters because those assumptions sit underneath the price of every long-dated promise.
Care and connection →Owners Reportedly Explore $1 Billion Sale of Largest US Senior Living Operator
The investors behind the largest senior living operator in the United States are reportedly looking for a buyer, and the price being discussed is about $1 billion.
Brain health →
Longevity & Healthspan · Long reads
A 6.3-Million-Cell Brain Atlas Finds Alzheimer's Is Not Just Faster Aging
A Nature study of brain tissue from 1,494 donors maps gene activity across eight brain disorders. Severe Alzheimer's shows fewer neurons and more immune and vascular cells, in a pattern distinct from healthy aging. It is a map, not a treatment.
Brain health →Does Annual Flu Vaccination Blunt the Next Shot? A Korean Trial Is Testing It
A registered Phase 4 trial compares standard-dose, adjuvanted and high-dose flu vaccines in adults 65 and older, with a younger reference group, over up to three years of annual shots. We read the full registry record: it started (estimated) on 21 September 2026 and is recruiting. It measures immune responses only, not infections or hospitalizations.
Reading medical evidence →Does Where Stem Cells Fail Matter as Much as How Many?
Our research desk borrows from mine engineering to propose, as an untested hypothesis it rates at 60 percent, that clustered stem-cell loss overloads neighbors and speeds telomere failure, while the same loss scattered does not. Recent skin biology makes the premise more plausible than it first sounds.
Brain health →Does Fading Nitric Oxide Silence Cell Recycling in Aging Arteries? Evidence Points the Other Way
Our research desk proposes that falling nitric oxide in blood vessels switches off TFEB, the master switch for cellular recycling, tying two hallmarks of aging together. Published studies support a connection, but mostly show recycling protecting nitric oxide, not the reverse. We found no study showing that nitric oxide or eNOS regulates TFEB, so the key link remains unconfirmed, and that is the weakest point of the argument.
Strength and function →
Markets & Strategy · Long reads
C2N, Cambridge Cognition and a New Alzheimer's Trust Bundle UK Dementia Testing Into One Pathway
The UK partnership links a blood test, a digital cognitive assessment and imaging infrastructure. It is an organized service, not yet proof that it shortens the road to diagnosis.
Brain health →Refiner Stocks Have Doubled in 2026 as the World Runs Short of Diesel
The shortage is in refined fuel, not crude oil. War damage to refineries in the Middle East and Russia has left the world short of diesel, gasoline and jet fuel. Three large U.S. refiners have more than doubled this year. Here is what is driving it, and why it may not last.
Longevity in daily life →
Measurement & AI
Cloudflare Plans a Post-Quantum Certificate Authority Using Merkle Tree Certificates
Cloudflare announced on 29 September 2026 that it is becoming a public certificate authority issuing free Merkle Tree Certificates (MTCs) alongside classical certificates, with production issuance targeted for early 2027. Approvals from the major browser root programs and a root-key deal with GlobalSign were not complete as of late September, so the rollout is a plan, not a finished fact.
Reading medical evidence →Rule-Last Prompts and Hostile Filenames: Our First Test Did Not Finish
Our research desk set out to test whether moving a rule to the end of a prompt makes AI models harder to trick with malicious filenames. This is a proposal, not a finding, and the idea is not new. The registered experiment ran out of time, and a partial run from another worker looks promising but does not count.
Reading medical evidence →
Science & Frontiers
Can Earth's Magnetic Field Help Microbes Clear Toxic Sulfide? A Long Shot
Our research desk proposes that compass-carrying bacteria, steered by Earth's field, remove enough sulfide from shallow sediments to make more room for animals. Each link is individually plausible, but the supporting lab work comes from freshwater organisms, while the proposed test uses coastal sediment. Whether the links add up is unknown.
Longevity in daily life →After Gene Editing, Do Corrected Cells Gain or Lose Ground Over Time?
Our research desk proposes that the fraction of cells fixed by a gene therapy is not fixed at all. It drifts and gets selected, like lineages in a small population, and should be measured that way. This is a hypothesis, not a finding. In liver, part of it is already known, so the novelty lies in neutral targets.
Longevity in daily life →
History & Ideas
Losing Experts All at Once May Destroy Skills That Gradual Turnover Would Not
Our research desk proposes that a community can survive losing skilled people one by one, yet lose a complex practice when the same people leave together. The idea borrows from how clustered supernovae clear gas from galaxies. It has a clean test.
Strength and function →Did Selection Start Before Life? A Testable Idea About Chemistry That Remembers
Our research desk proposes that complexity piles up wherever surviving structures shape what forms next, even in non-living chemistry. The idea fits life and culture well, early chemistry plausibly, and the Big Bang not at all.
Brain health →